Atlas Trials

A Study to Evaluate Clinical Effect, Pharmacokinetics , Safety, and Tolerability of Umeclidinium in Palmar Hyperhidrosis Subjects

Clinical trial NCT02673619 · COMPLETED

Trial details

NCT number
NCT02673619
Sponsor
Stiefel, a GSK Company
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Hyperhidrosis
Start date
2016-03-07
Primary completion
2016-12-08
Enrollment
58

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.